What’s up with… Telus, ISAC, Vodafone Ireland
Telus reported a C$660m net loss in Q3, with C$5bn revenue (down 1% YoY) and C$1.8bn EBITDA (down 5% YoY). The company plans C$900m annual savings by 2028, including an C$800m impairment charge for Telus Health. Vodafone Ireland will begin 5G standalone trials later this year. ETSI published a report on integrating computing with ISAC for 6G services.
How this was made

The 30-second read
Why it matters
The earnings miss and impairment likely trigger short‑term sell‑off, but the announced C$900M efficiency program may support a turnaround narrative.
Market read
Telus' results provide a fresh data point for telecom investors and may influence sector sentiment on cost‑control measures.
What to watch
Board additions bring experienced telecom leadership that may accelerate transformation.
Background
Telus is a leading Canadian telecom and AI infrastructure provider; the quarter showed revenue decline and a sizable health‑unit impairment.
Ticker impact
Telus reported a C$660M quarterly net loss and announced a C$900M annual cost‑saving plan, plus a C$800M health‑unit writedown.
likely pressure as the market prices in the earnings miss and impairment charge
Earnings miss and large non‑cash charge are immediate negative catalysts; the cost‑saving plan is a future benefit but may not offset near‑term sell‑off.
Market effects
Canadian telecom sector may see broader scrutiny as peers evaluate cost structures after Telus' loss.
Potential modest drag on the TSX telecom index.
Limited; primarily affects North American telecom investors.
Counterpoint
Cost‑saving plan could eventually improve margins, offering a buying opportunity on dip.
Key entities
- companyTelus Corp.
Canadian telecom operator reporting quarterly loss and cost‑saving plan.
- personVictor Dodig
Telus CEO commenting on transformation strategy.


